Results 111 to 120 of about 2,741 (176)

Role of Hippo Pathway Effector Tafazzin Protein in Maintaining Stemness of Umbilical Cord-Derived Mesenchymal Stem Cells (UC-MSC) [Elektronisk resurs]

open access: yes, 2018
Tafazzin (TAZ) protein has been upregulated in various types of human cancers, although the basis for elevation is uncertain, it has been made definite that the effect of mutation in the hippo pathway, particularly when it is switched off, considerably ...
Gopinath, Madhumala,   +11 more
core  

Stimulating the sir2–spargel axis rescues exercise capacity and mitochondrial respiration in a Drosophila model of Barth syndrome

open access: yesDisease Models & Mechanisms, 2022
Deena Damschroder   +5 more
doaj   +1 more source

Corrigendum: Re-expression of tafazzin isoforms in TAZ-deficient C6 glioma cells restores cardiolipin composition but not proliferation rate and alterations in gene expression

open access: yesFrontiers in Genetics, 2022
Gayatri Jagirdar   +11 more
doaj   +1 more source

De novo synthesis of cardiolipin controls respiratory chain biogenesis in neonatal mouse hearts. [PDF]

open access: yesEMBO Rep
Ren M   +5 more
europepmc   +1 more source

The impact of Tafazzin deficiency on the functional and immunological characteristics of B lymphocytes

open access: yes, 2022
Barth syndrome (BTHS) is a rare X-linked genetic disease classically characterized by cardiomyopathy, skeletal myopathy, and neutropenia. It is caused by mutations in the TAFAZZIN gene, which codes for the protein tafazzin (Taz), and this results in alterations in the level and molecular composition of the mitochondrial phospholipid cardiolipin with ...
openaire   +1 more source

Cross-species evidence for cardiolipin remodeling in neonatal hypoxic-ischemic encephalopathy. [PDF]

open access: yesJ Cereb Blood Flow Metab
Emaus KJ   +9 more
europepmc   +1 more source

Metabolic cardiomyopathies: untangling clinical heterogeneity with human stem-cell derived models. [PDF]

open access: yesEMBO Mol Med
Passadouro AS   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy